| Name | Budigalimab |
|---|---|
| Synonyms |
Budigalimab (anti-PD-1)
ade Budigalimab ade Budigalimab (DHH02210) |
| Description | Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function[1]. |
|---|---|
| Related Catalog | |
| Target |
programmed cell death 1 (PD-1) receptor[1] |
| References |
| No Any Chemical & Physical Properties |